Rosalie Elenitsas, MD
she/her/hers
Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Radnor
View 1 additional location
Make an appointmentCall 610-902-2400
Penn Medicine Provider

About me

  • Director, Dermatopathology
  • Director, Dermatopathology Fellowship Program
  • Herman Beerman Professor
  • Professor of Dermatology in Pathology and Laboratory Medicine

Education and training

  • Medical School: University of Pittsburgh
  • Residency: Mercy Providence Hospital/UPMC Passavant Hospital
  • Residency: University of Pittsburgh School of Medicine
  • Fellowship: University of Pennsylvania Health System

What my patients think about me

Average Rating

97 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

December 2025
she is brilliant , is full of knowledge and spends as much time as you need with her. she goes above and beyond to meet the patient's needs despite her extremely busy clinical and academic commitments. there is no one better.
November 2025
she is an excellent physician who practices with incredible skill and empathy
October 2025
prompt, professional, fantastic expertise, explains findings with pros & cons of options, patient, compassionate, down to earth
October 2025
on time, great appt, personable

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Elenitsas is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Hirai I, Walker JL, Rubin AI, Chu EY, Elenitsas R CRTC1::TRIM11 Cutaneous Tumor Mimicking Primary Dermal Melanoma: Case Report With Literature Review , Am J Dermatopathol: 2025,971-975

Goldman-Lévy G, Barnhill R, Bastian BC, Kempf W, Elder D, Gerami P, Grayson W, Kazakov D, Massi D, Messina J, de la Fouchardière A, Lazar AJ, Brenn T, Rous B, Field A, Gill A, Hodge JC, Khoury JD, Leite K, Sayed S, Tan PH, Elenitsas R, Calonje E, Duncan LM, Zhiyong L, Moch H, Singh R, Wijesinghe H, Cree I, Lokuhetty D. WHO Classification of Skin Tumours,5th edition , Histopathology: 2025

Koh E, Jiang A, Lee DY, Park JH, Elenitsas R, Rubin A Melanocyte Remnants in the Nail Plate: Recognizing Histopathologic Features and Distinguishing from Common Mimickers , The American Society of Dermatopathology Annual Meeting, Baltimore, MD: 2025

Lehman JS, Fernandez AP, Leiferman KM, Brinster NK, Culton DA, Kim RH, North JP, Stoff BK, Camilleri MJ, Cocks MM, Elenitsas R, Fung MA, Grover RK, Jedrych JJ, Kuechle MK, McNiff JM, Moshiri AS, Motaparthi K, Murphy MJ, Nousari CH, Shalin SC, Zone JJ, Bridges AG Assessment of Cutaneous and Mucosal Direct Immunofluorescence Testing Practices in the US , JAMA Dermatol: 2025,747-754

Valdes Morales KL, Bornstein M, Hannah CE, Vazquez T, Rauck C, Rodriguez O, Elenitsas R, Ammazzalorso A, Sahrish I, Weikert BC, Baumrin E, Sivendran M, Forrestel A, Rosenbach M Cytomegalovirus anogenital ulcers in an immunosuppressed patient , JAAD Case Rep: 2025,112-115

Hirai I, Walker J, Rubin AI, Chu EY, Elenitsas R Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion , International Society of Dermatopathology, Orlando FL: 2025

Duncan LM, Barnhill RL, Chu EY, Elenitsas R, Landman G, Massi D, Mihm MC Jr, Piepkorn M Low-CSD melanoma (including superficial spreading melanoma) , WHO Classification of Skin Tumours,5th edition: 2025,138-140

Lowe L, Barnhill RL, Brenn T, Elenitsas R, Zalaudek I Recurrent naevus , WHO Classification of Skin Tumours,5th edition: 2025,126-127

Xu X, Barnhill RL, Brenn T, Chu EY, Elenitsas R, Zalaudek I Halo naevus , WHO Classification of Skin Tumours,5th edition: 2025,123-124

Duncan LM, Barnhill RL, Elenitsas R, Mihm MC Jr, Piepkorn M Simple lentigo and lentiginous melanocytic naevus , WHO Classification of Skin Tumours,5th edition: 2025,113-114